By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Chiesi Farmaceutici SpA 

Via Palermo 26/ A

Parma    43100  Italy
Phone: 39-0521-279-230 Fax: 39-0521-774468



Company News
Veloxis Pharma (VELO) Announces Agreement With Chiesi Farmaceutici SpA To Commercialize Envarsus XR In China 6/6/2017 8:43:36 AM
Charles River  (CRL) And Chiesi Farmaceutici SpA Announce Extension Of Integrated Respiratory Drug Discovery Program 3/13/2017 6:34:34 AM
Aptuit LLC And Chiesi Farmaceutici SpA Initiate Integrated Discovery Project To Identify Novel Compounds For The Treatment Of Idiopathic Pulmonary Fibrosis 1/4/2017 10:45:02 AM
Chiesi Farmaceutici SpA Pays $80 Million for Atopix 's Asthma Portfolio 11/21/2016 6:48:37 AM
The Medicines Company (MDCO) Agrees To Divest Non-Core Cardiovascular Assets To Chiesi Farmaceutici SpA 5/9/2016 11:13:23 AM
The Medicines Company (MDCO) Divests Cardiovascular Assets to Chiesi Farmaceutici SpA for Up to $792 Million 5/9/2016 6:02:25 AM
Kamada Ltd. (KMDA) Receives Two Milestone Payments Under Strategic Agreements With Chiesi Farmaceutici SpA And Baxalta (BXLT) 5/2/2016 9:48:17 AM
uniQure And Chiesi Farmaceutici SpA Announce Six Year Follow-up Data from Glybera® Treated Patients 3/17/2014 8:58:30 AM
Chiesi Farmaceutici SpA Completes Acquisition Of Cornerstone Therapeutics Inc. 2/4/2014 9:58:06 AM
Selvita Extends Long-Term Chemistry Collaboration With Chiesi Farmaceutici SpA 1/10/2014 10:12:55 AM